| Target Price | $17.34 |
| Price | $10.32 |
| Potential |
68.02%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Lumexa Imaging 2027 .
The average Lumexa Imaging target price is $17.34.
This is
68.02%
register free of charge
$24.15
134.01%
register free of charge
$13.13
27.23%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Lumexa Imaging to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Lumexa Imaging stock has an average upside potential 2027 of
68.02%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.02 | 1.09 |
| 7.82% | 6.35% | |
| EBITDA Margin | 6.56% | 22.28% |
| 140.02% | 239.55% | |
| Net Margin | -4.60% | 7.03% |
| 53.58% | 252.70% |
10 Analysts have issued a sales forecast Lumexa Imaging 2026 . The average Lumexa Imaging sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Lumexa Imaging EBITDA forecast 2026. The average Lumexa Imaging EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Lumexa Imaging Analysts have issued a net profit forecast 2026. The average Lumexa Imaging net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.49 | 0.80 |
| 51.00% | 263.27% | |
| P/E | 12.97 | |
| EV/Sales | 1.67 |
10 Analysts have issued a Lumexa Imaging forecast for earnings per share. The average Lumexa Imaging EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keybanc |
Locked
➜
Locked
|
Locked | Sep 25 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 28 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | May 20 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 14 2026 |
| Raymond James |
Locked
➜
Locked
|
Locked | Feb 09 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jan 05 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Jan 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Keybanc:
Locked
➜
Locked
|
Sep 25 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 28 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
May 20 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 14 2026 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Feb 09 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jan 05 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Jan 05 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


